Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara Abulez

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Proteomics|April 20, 2025
Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancerAllison L Hunt, Waleed Barakat, Sasha C Makohon-Moore, et al.
Clinical & Experimental Metastasis|November 2, 2023
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic studyAllison L Hunt, Imran Khan, Alex M L Wu, et al.
Gynecologic Oncology|September 27, 2025
Silva pattern-guided proteomics reveals coordinated tumor-stroma remodeling in cervical adenocarcinomaSara M Drayer, Jonathan D Ogata, Sean Cronin, et al.
NPJ Precision Oncology|April 15, 2025
Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boardsAllison L Hunt, Jamie Randall, Mahesh M Mansukhani, et al.
Cancers|March 25, 2022
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.
Scientific Reports|March 15, 2026
Immunoproteomic insights into inflammatory diseases of the critically endangered black rhinoceros (Diceros bicornis)Molly L Corder, Tamara Abulez, Timothy Cleland, et al.
Scientific Reports|May 1, 2021
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patientsNicholas W Bateman, Christopher M Tarney, Tamara Abulez, et al.
Gynecologic Oncology|August 28, 2023
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Proteomics|April 20, 2025
Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancerAllison L Hunt, Waleed Barakat, Sasha C Makohon-Moore, et al.
Clinical & Experimental Metastasis|November 2, 2023
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic studyAllison L Hunt, Imran Khan, Alex M L Wu, et al.
Gynecologic Oncology|September 27, 2025
Silva pattern-guided proteomics reveals coordinated tumor-stroma remodeling in cervical adenocarcinomaSara M Drayer, Jonathan D Ogata, Sean Cronin, et al.
NPJ Precision Oncology|April 15, 2025
Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boardsAllison L Hunt, Jamie Randall, Mahesh M Mansukhani, et al.
Cancers|March 25, 2022
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerDeanna Glassman, Nicholas W Bateman, Sanghoon Lee, et al.
Scientific Reports|March 15, 2026
Immunoproteomic insights into inflammatory diseases of the critically endangered black rhinoceros (Diceros bicornis)Molly L Corder, Tamara Abulez, Timothy Cleland, et al.
Scientific Reports|May 1, 2021
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patientsNicholas W Bateman, Christopher M Tarney, Tamara Abulez, et al.
Gynecologic Oncology|August 28, 2023
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
Pageof 2